| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |